Polymorphism of COVID-19 dermatological manifestations: Pandemic experience
https://doi.org/10.34215/1609-1175-2024-2-70-73
Abstract
Although the incidence of COVID-19 infection is decreasing, the clinical experience gained during the pandemic remains relevant. In this article, we present clinical cases from our own practice to describe non-standard variants of the development of COVID-19-associated skin pathology in patients of different age groups and during different periods of the infectious process. The conducted analysis of the presented cases revealed the following: systemic pathological processes caused by COVID-19 lead to the development of dermatological symptoms; different strains of SARS-CoV-2 can cause different dermatological symptoms in the same patient; skin rashes appeared as a manifestation of post-Covid syndrome may recur in case of COVID-19 reinfection; immune deviations that developed after COVID-19 infection subsequently lead to clinical pathomorphism of skin diseases; vaccination against COVID-19 may trigger relapses of chronic dermatoses.
About the Authors
O. B. Nemchaninova
Novosibirsk State Medical University
Russian Federation
Russian Federation
Novosibirsk
T. B. Reshetnikova
Novosibirsk State Medical University
Russian Federation
Russian Federation
Novosibirsk
O. N. Pozdnyakova
Novosibirsk State Medical University
Russian Federation
Russian Federation
Novosibirsk
E. Y. Sklyanova
Novosibirsk State Medical University
Russian Federation
Russian Federation
Novosibirsk
E. N. Makhnovets
Novosibirsk State Medical University
Russian Federation
Russian Federation
Evgeny N. Makhnovets, Cand. Sci. (Med.), Associate Professor of the Department of Dermatovenerology and Cosmetology
52 Krasny prospect, Novosibirsk, 630091
References
1. COVID-19 epidemiological update – 22 December 2023. URL: https://www.who.int/publications/m/item/covid-19-epidemiological-update---22-december-2023 (Accessed December 22, 2023).
2. COVID-19 cases. WHO Information Panel on COVID-19. URL: COVID-19 cases | WHO COVID-19 dashboard (Accessed January 17, 2024).
3. Recalcati S, Barbagallo T, Frasin LA, Prestinari F, Cogliardi A, Provero MC, Dainese E, Vanzati A, Fantini F. Acral cutaneous lesions in the time of COVID-19. J Eur Acad Dermatol Venereol. 2020;34(8):346–7. doi: 10.1111/jdv.16533
4. Liu W, Zhang Q, Chen J, Xiang R, Song H, Shu S, Chen L, Liang L, Zhou J, You L, Wu P, Zhang B, Lu Y, Xia L, Huang L, Yang Y, Liu F, Semple MG, Cowling BJ, Lan K, Sun Z, Yu H, Liu Y. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China. N Engl J Med. 2020;382(14):1370–1. doi: 10.1056/NEJMc2003717
5. Zheng F, Liao C, Fan QH, Chen HB, Zhao XG, Xie ZG, Li XL, Chen CX, Lu XX, Liu ZS, Lu W, Chen CB, Jiao R, Zhang AM, Wang JT, Ding XW, Zeng YG, Cheng LP, Huang QF, Wu J, Luo XC, Wang ZG, Zhong YY, Bai Y, Wu XY, Jin RM. Clinical characteristics of children with Coronavirus Disease 2019 in Hubei, China. Curr Med Sci. 2020;40(2):275–80. doi: 10.1007/s11596-020-2172-6
6. Marzano AV, Genovese G, Fabbrocini G, Pigatto P, Monfrecola G, Piraccini BM, Veraldi S, Rubegni P, Cusini M, Caputo V, Rongioletti F, Berti E, Calzavara-Pinton P. Varicella-like exanthem as a specifi c COVID-19-associated skin manifestation: multicenter case series of 22 patients. J Am Acad Dermatol. 2020;83(1):280–5. doi: 10.1016/j.jaad.2020.04.044
7. Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, Baxter-Stoltzfus A, Laurence J. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of fi ve cases. TranslRes. 2020; 220:1–13. doi: 10.1016/j.trsl.2020.04.007
8. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock inchildren during COVID-19 pandemic. Lancet. 2020;395:(10237):1607–8. doi: 10.1016/S0140-6736(20)31094-1
9. Dvornikov AS, Silin AA, Gaidina TA, Larina VN, Skripkina PA, Kiva EV. Skin manifestations in coronavirus disease 2019 (COVID-19). Th e Russian Archives of Internal Medicine.2020;10(6):422–29 (In Russ.)]. doi: 10.20514/2226-6704-2020-10-6-422-429
10. Kosheleva IV, Bitkina OA, Shadyzheva LI, Andriyakhina OV, Nikolaeva AYu, Fyrnina MN, Deryavaya MA, Pershina KS, Zueva DS, Tsyganova AA. On the issue of dermatological aspects of a new coronavirus infection (COVID-19). Farmateka. 2021; No. 8:42–7 (In Russ.)]. doi: 10.18565/pharmateca.2021.8.42-47
11. Maliyar K, Sachdeva M, Mufti A, Yeung J. Reply To: Skin Damage Among Healthcare Workers Managing Coronavirus disease-2019. J Am Acad Dermatol. 2020; 83(2):169–70. doi: 10.1016/j.jaad.2020.05.037
12. Fu Y, Cheng Y, Wu Y. Understanding SARS-CoV-2-mediated infl ammatory responses: from mechanisms to potential therapeutic tools. Virol Sin. 2020; 1–6. doi: 10.1007/s12250-02000207-4
13. Nemchaninova OB, Simonova ЕP. Dermatological manifestations associated with a novel coronavirus infection in the acute and post-acute period of COVID-19. Journal of Siberian Medical Sciences. 2023;7(1):7–17 (In Russ.)]. doi: 10.31549/2542-1174-2023-7-1-7-17
Review
For citations:
Nemchaninova O.B., Reshetnikova T.B., Pozdnyakova O.N., Sklyanova E.Y., Makhnovets E.N. Polymorphism of COVID-19 dermatological manifestations: Pandemic experience. Pacific Medical Journal. 2024;(2):70-73. (In Russ.) https://doi.org/10.34215/1609-1175-2024-2-70-73
Views:
320
Email this article 